- Home
- RYM
RYM
RYTHM Inc.
as 11-19-2025 9:30am EST
Rythm Inc is a USA Based company. The Company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | ROLLING MEADOWS |
| Market Cap: | 75.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 23.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -23.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.22 - $84.44 | Next Earning Date: | 11-07-2025 |
| Revenue: | $16,303,000 | Revenue Growth: | 368.50% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of RYTHM Inc. (RYM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Vakili Armon | RYM | Director | Sep 9 '25 | Sell | $38.23 | 1,900 | $72,632.63 | 8,100 | |
| Kovler Benjamin | RYM | Interim CEO | Sep 3 '25 | Buy | $36.70 | 1,000 | $36,700.00 | 17,000 | |
| Kovler Benjamin | RYM | Interim CEO | Sep 2 '25 | Buy | $46.70 | 1,000 | $46,700.00 | 17,000 | |
| Holtzman Max | RYM | Director | Aug 29 '25 | Sell | $43.54 | 5,000 | $213,559.61 | 6,100 |
Latest RYTHM Inc. News
RYM Breaking Stock News: Dive into RYM Ticker-Specific Updates for Smart Investing
Compare RYM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RYM RYTHM Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.